Skip to Content
Merck

Iatrogenic Cushing syndrome due to nasal steroid drops.

European journal of pediatrics (2011-12-29)
Veysel Nijat Baş, Semra Cetinkaya, Zehra Aycan
ABSTRACT

Iatrogenic Cushing syndrome may occur as an undesirable outcome of high-dose glucocorticoids treatments. This may also cause hypothalamus-hypophysis-adrenal axis suppression. While this situation may be caused more frequently with oral and topical glucocorticoid therapy, iatrogenic Cushing syndrome in childhood, caused by steroid-containing nasal drops, is a rare event. Hereby, we present a baby who developed iatrogenic Cushing syndrome induced by long-term use of steroid-containing nasal drops for choanal atresia. In conclusion, the serious side effects of the nasal drops should have been explained to the family, and their long-term use should have been refrained.

MATERIALS
Product Number
Brand
Product Description

Dexamethasone sodium phosphate, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Dexamethasone 21-phosphate disodium salt, ≥98%